Subscribe To
Intuitive machines stock climbs on lunar mission plan as mcdonald's edges higher ahead of results
Coherus BioSciences stock CHRS, -3.65% rose 17% as the Food and Drug Administration approved its treatm...
October 30, 2023, 5:20 am
Bitcoin and cryptocurrency atms market future outlook and prospects till 2030 | 101 pages report
Worldwide ” Bitcoin and Cryptocurrency atms Market ” Research Report 2023 is spread across 101+ Pag...
October 30, 2023, 4:44 am
Update — scilex holding company files emergency motion in the united states bankruptcy court for the southern district of texas for entry of an order compelling the production of books and records fro
PALO ALTO, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-gene...
October 27, 2023, 7:38 pm
Ironwood pharmaceuticals: the right play now
Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gast...
October 27, 2023, 4:13 pm
Acumen pharmaceuticals presents late-breaker phase 1 updates exploring novel target engagement, dosing regimen and safety findings for acu193 in early alzheimer’s disease at the 16th annual clinical t
– Acumen presented data exploring target engagement modeling of ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibody, to...
October 27, 2023, 1:25 pm
Treace medical concepts continues growth investments despite high operating losses
Treace Medical Concepts, Inc. sells medical device treatments for foot bunions. The global market for b...
October 27, 2023, 12:09 pm
Xencor: data in early 2024 could bring shareholder value
Xencor is expected to release data from a phase 2 study in early 2024 targeting patients with mCRPC and gynecological cancers, which could generate sh...
October 27, 2023, 11:56 am
Natwest shares plunge as bank cuts guidance and admits ‘serious failings' in treatment of brexit campaigner nigel farage
Shares in NatWest NWG, -11.37% fell 12% on Friday after the British bank cut its guidance and admitted “serious failings” in its tre...
October 27, 2023, 9:11 am
Why lianbio stock is shooting through the roof this week
LianBio has entered into a major deal with Bristol Myers Squibb. Bristol Myers will pay $350 million for the rights to develop and commercialize LianB...
October 27, 2023, 8:32 am
Consolidated water sets third quarter 2023 investor conference call for friday, november 10, 2023 at 11:00 a.m. et
GEORGE TOWN, Cayman Islands, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer an...
October 27, 2023, 8:31 am
Medicinova’s collaborator initiates clinical development of a gene therapy product for the treatment of phenylketonuria
LA JOLLA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
October 27, 2023, 5:00 am
Natwest plunges 11% after cutting outlook, farage fall-out
NatWest Group PLC (LSE:NWG) shares plunged 11% in early exchanges after it lowered full-year net interest margin guidance and admitted "serious failin...
October 27, 2023, 4:01 am
Natwest admits to "serious failings" in treatment of nigel farage
NatWest Group PLC (LSE:NWG) has admitted to “serious failings” in the treatment of Nigel Farage and...
October 27, 2023, 2:58 am
Catalyst pharmaceuticals reports fda approval of agamree® (vamorolone) for duchenne muscular dystrophy granted to santhera pharmaceuticals
AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Ol...
October 26, 2023, 7:19 pm
Lawsuit seeks equal treatment for cannabis businesses
Federal criminalization of safe, regulated intrastate cannabis legal in 38 states is unconstitutional—and unfair to small businessesCannabis … Rea...
October 26, 2023, 6:32 pm
Paxmedica’s research on low dose suramin for autism spectrum disorder accepted for publication
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) — via IBN — PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage biopharmaceutical company, is excited...
October 26, 2023, 5:51 pm
Why blueprint medicines stock soared today
Blueprint Medicines delivered an exceptional quarter with a positive reception for Ayvakit in its first full-quarter post-launch. More than 800 patien...
October 26, 2023, 5:47 pm
Bristol myers squibb revenue falls on generic competition for key drug
Shares of Bristol Myers Squibb (BMY) fell Thursday after the company reported that sales of the drug maker's popular Revlimid blood cancer tre...
October 26, 2023, 4:55 pm
Why novocure stock was sick today
The cancer treatment device developer released its latest set of quarterly results. These were a mixed ...
October 26, 2023, 4:35 pm
Shockwave medical announces details for conference call discussing third quarter 2023 results and participation in upcoming investor conference
SANTA CLARA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of t...
October 26, 2023, 4:30 pm